Last reviewed · How we verify

NCT03620448

Immediate Treatment Outcomes of b-CPAP vs Oxygen Therapy in Preterm Babies Presenting With RDS at KCMC

Completed NA Last updated 8 August 2018
What this trial tests

NA trial testing bCPAP Arm in Respiratory Distress Syndrome in Premature Infant in 48 participants. Completed in 15 May 2017.

Timeline
15 December 2016
Primary endpoint
15 May 2017
15 May 2017

Quick facts

Lead sponsorKilimanjaro Christian Medical Centre, Tanzania
PhaseNA
StatusCompleted
Study typeINTERVENTIONAL
Allocationrandomized
Designparallel
Maskingnone
Primary purposetreatment
Enrollment48
Start date15 December 2016
Primary completion15 May 2017
Estimated completion15 May 2017

Drugs / interventions tested

Conditions studied

Sponsor

Kilimanjaro Christian Medical Centre, Tanzania

Who can join

Adults 28 Weeks to 37 Weeks, any sex, with Respiratory Distress Syndrome in Premature Infant. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

Bubble - Continuous positive airway pressure (CPAP) has been reported to be effective, cheaper, simpler and more accessible compared to mechanical ventilator and surfactant treatment for preterms with respiratory distress syndrome in the neighbouring countries. This study aims to implement and determine the effectiveness of bCPAP and its immediate outcomes compared to oxygen therapy in preterm babies presenting with respiratory distress syndrome (RDS).

Publications & conference data

1 peer-reviewed publication reference this trial (live from Europe PMC):

  1. Treatment outcomes of Pumani bubble-CPAP versus oxygen therapy among preterm babies presenting with respiratory distress at a tertiary hospital in Tanzania-Randomised trial.
    Mwatha AB, Mahande M, Olomi R, John B, et al · · 2020 · cited 20× · PMID 32603380 · DOI 10.1371/journal.pone.0235031

Verify or expand the search:

Other recruiting trials for Respiratory Distress Syndrome in Premature Infant

Currently open trials in the same condition.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03620448.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing